Quinobenzothiaziny-lbutane-sulfonate-cpd9
General
Type : Phenothiazine, Antioxidant, Sulfur Compound
Chemical_Nomenclature : 4-(quino[3,2-b]benzo[1,4]thiazin-6-yl)butane-1-sulfonic acid
Canonical SMILES : C12=C(C=CC=C1)SC3=C(N2CCCC[S](=O)(=O)O)N=C4C(=C3)C=CC=C4
InChI : InChI=1S\/C19H18N2O3S2\/c22-26(23,24)12-6-5-11-21-16-9-3-4-10-17(16)25-18-13-14-7-1-2-8-15(14)20-19(18)21\/h1-4,7-10,13H,5-6,11-12H2,(H,22,23,24)
InChIKey : PMCJSXFWDQZPTQ-UHFFFAOYSA-N
Other name(s) : Compound 9
Target
Families : Quinobenzothiaziny-lbutane-sulfonate-cpd9 ligand of proteins in family
Pancreatic_lipase
Cholesterol_esterase
Protein :
human-PNLIP
human-CEL
References (1)
| Title : A Study of Antioxidant, Antihyperlipidemic, and Anti-Glycation Effects of Alkylsulfonic Acids with Quinobenzothiazinyl Substituents: In Vitro and In Silico Investigations - Anamalay_2025_Antioxidants.(Basel)_14_464 |
| Author(s) : Anamalay K , Er LQ , Balachandran A , Okechukwu PN , Morak-Mlodawska B , Billacura MP , Lavilla CA, Jr. , Abdul Rani AN , Gaurav A , Konefal A , Jelen M |
| Ref : Antioxidants (Basel) , 14 :464 , 2025 |
| Abstract : |
| PubMedSearch : Anamalay_2025_Antioxidants.(Basel)_14_464 |
| PubMedID: 40298778 |